Reduced fungal contamination of the indoor environment with the Plasmair system (Airinspace).
Fiche publication
Date publication
février 2007
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BONNIN Alain, Dr CAILLOT Denis
Tous les auteurs :
Sixt N, Dalle F, Lafon I, Aho S, Couillault G, Valot S, Calinon C, Danaire V, Vagner O, Cuisenier B, Sautour M, Besancenot JP, L'Ollivier C, Caillot D, Bonnin A
Lien Pubmed
Résumé
Aspergillus spp. and other moulds cause life-threatening opportunistic infections in immunocompromised patients. Indoor contamination and construction work that liberate fungal spores are a major source of nosocomial aspergillosis. Dijon hospital is a tertiary care institution in northeast France undergoing construction work beside high-risk clinical units. To determine the impact of this activity, a surveillance programme was implemented one year before building work began in order to establish baseline levels of contamination. Air and surface fungal contamination in adult and paediatric haematology units were prospectively examined following use, or not, of a new air-treatment system with mobile Plasmair units (Airinspace). There were significant reductions in overall fungal contamination for the Plasmair treated rooms for air and surface samples in both clinical units. Plasmair treatment also significantly reduced A. fumigatus in the air. These data suggest that Plasmair units may provide an efficient method of reducing indoor fungal contamination in hospitals.
Référence
J Hosp Infect. 2007 Feb;65(2):156-62